SIRT3 protects endothelial cells from high glucose-induced senescence and dysfunction via the p53 pathway

Life Sci. 2021 Jan 1:264:118724. doi: 10.1016/j.lfs.2020.118724. Epub 2020 Nov 5.

Abstract

Hyperglycemia induces endothelial cells (ECs) dysfunction and vascular complications by accelerating ECs senescence. It also induces downregulation of sirtuins (SIRTs). However, the molecular mechanism involved in the regulation of ECs senescence by SIRT3 remains unclear. Here, we showed that high glucose (HG) decreased the expression level of SIRT3 in human umbilical vein endothelial cells (HUVECs), increased the proportion of cells expressing senescence-associated galactosidase (SA-gal), and HG damaged the cell's ability to form tubule networks on Matrigel. However, transfection with adenoviral construct including SIRT3 significantly inhibited HG-induced SA-gal activity, decreased p53 acetylation level at the site Lys 320 (k320), and overexpression of SIRT3 antagonized high glucose-induced angiogenic dysfunction. Our results suggested a possible molecular mechanism involving HG-SIRT3-p53 in ECs senescence.

Keywords: Endothelial senescence; High glucose; SIRT3; p53.

MeSH terms

  • Acetylation / drug effects
  • Cellular Senescence* / drug effects
  • Cytoprotection* / drug effects
  • Down-Regulation / drug effects
  • Gene Silencing / drug effects
  • Glucose / toxicity*
  • Human Umbilical Vein Endothelial Cells / drug effects
  • Human Umbilical Vein Endothelial Cells / pathology*
  • Humans
  • Lysine / metabolism
  • Phenotype
  • Protective Agents / pharmacology*
  • Protein Stability / drug effects
  • Signal Transduction* / drug effects
  • Sirtuin 3 / metabolism*
  • Tumor Suppressor Protein p53 / metabolism*

Substances

  • Protective Agents
  • Tumor Suppressor Protein p53
  • Sirtuin 3
  • Glucose
  • Lysine